Watchdog Group Opposes CA Director D'Amato
A corporate watchdog group is advising shareholders of CA (CA) to withhold their votes from director Alfonse D'Amato and to defeat a proposal that would require a unanimous vote of the board to initiate or extend a poison pill defense.
Proxy Governance, an advisory service, noted that D'Amato has been on the board since 1999, "a period when the Long Island-based software company confronted accounting scandals, financial restatements and executive departures."
The company was formerly known as Computer Associates.
The advisory service said it is best that the company be able to start fresh with directors that weren't on the board when the bulk of the troubles occurred. For that reason, it believes "it is best that former Senator D'Amato not continue with the CA board."
Separately, Proxy Governance recommended rejection of a bylaw proposal by Harvard law professor Lucian Bebchuk to require unanimous board consent to adopt or extend a poison pill not approved by shareholders. Any such pill would expire after one year and any change to the bylaw would similarly require unanimous board approval. CA's pill is scheduled to expire in November. "Proxy Governance believes this proposal is really bad governance, pure and simple," the group said in a press release. "The provision not only has questionable legality, but also could lead to a 'tyranny of one.'"Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV